tradingkey.logo
tradingkey.logo
Buscar

Allurion Technologies Inc

ALUR
Añadir a la lista de seguimiento
0.671USD
0.0000.00%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
5.50MCap. mercado
PérdidaP/E TTM

Más Datos de Allurion Technologies Inc Compañía

Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.

Información de Allurion Technologies Inc

Símbolo de cotizaciónALUR
Nombre de la empresaAllurion Technologies Inc
Fecha de salida a bolsaMar 29, 2021
Director ejecutivoGaur (Shantanu)
Número de empleados134
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 29
Dirección11 Huron Dr Ste 200
CiudadNATICK
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal01760
Teléfono15086474000
Sitio Webhttps://www.allurion.com/en
Símbolo de cotizaciónALUR
Fecha de salida a bolsaMar 29, 2021
Director ejecutivoGaur (Shantanu)

Ejecutivos de Allurion Technologies Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
4.13K
--
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
81.00
--
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Dr. Ram Chuttani
Dr. Ram Chuttani
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--
Mr. Nicholas Sheridan (Nick) Lewin
Mr. Nicholas Sheridan (Nick) Lewin
Independent Director
Independent Director
--
--
Mr. Mike Cavanaugh
Mr. Mike Cavanaugh
Investor Relations
Investor Relations
--
--
Mr. Keith Johns
Mr. Keith Johns
Independent Director
Independent Director
--
--
Mr. R. Jason Richey
Mr. R. Jason Richey
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
4.13K
--
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
81.00
--
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Dr. Ram Chuttani
Dr. Ram Chuttani
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Allurion Technologies Inc?

Los cinco principales accionistas de Allurion Technologies Inc son: Dr. Shantanu Gaur, M.D.

¿Cuántas instituciones poseen acciones de Allurion Technologies Inc (ALUR)?

A fecha de 2026Q1, 70 instituciones poseen acciones de Allurion Technologies Inc, con un valor de mercado combinado de aproximadamente 6.90M, lo que representa el 46.01% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 132951.00.